Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

British Journal of Clinical Pharmacology

Volumn 53, Issue 5, 2002, Pages 469-473

  Sturrock, N D C ^a,b   Lannon, B ^a   Fay, T N ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Androgens; Clomiphene; Insulin; Menstruation; Metformin; Ovulation; PCOS

Indexed keywords

CLOMIFENE; METFORMIN; ANTIDIABETIC AGENT; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFERTILITY; MENSTRUATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG RESISTANCE; FEMALE INFERTILITY; PREGNANCY RATE; TREATMENT FAILURE;

ADULT; CLOMIPHENE; COMPARATIVE STUDY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; FERTILITY AGENTS, FEMALE; HUMAN; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; METFORMIN; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; TREATMENT FAILURE; HUMANS;

EID: 0035999635     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01575.x     Document Type: Article

References (19)

1. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
2. Detection of functional ovarian hyperandrogenism in women with androgen excess
3. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
4. The insulin sensitising agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovarian syndrome
5. An overview of metformin in the treatment of type 2 diabetes mellitus
6. Effects of in-utero exposure to oral hypoglycaemic drugs
7. Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis
8. Ovarian tumours in a cohort of infertile women
9. Clinical and laboratory predictors of clomiphene response
10. Homeostatic model assessment. Insulin resistance and [beta]-cell function from plasma glucose and insulin concentration in man
11. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
12. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
13. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in Polycystic Ovary Syndrome: A randomized, double blind, placebo controlled 6-month trial, followed by open, long-term clinical evaluation
14. Effect of dietary weight loss on sex steroid binding, sex steroids, and gonadotrophins in obese premenopausal women
15. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-1
16. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women
17. Can metformin reduce insulin resistance in polycystic ovary syndrome?
18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the Polycystic Ovary Syndrome
19. Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study